Stanford group retracts JACS paper, but revisits and validates findings

A prominent Stanford University chemistry lab has been forced to retract a paper in the Journal of the American Chemical Society (JACS). According to the retraction notice:

Due to inconsistencies between some of the assigned structures and the experimental data that appear in the paper, the authors retract this publication. We regret very much this unfortunate occurrence.

The Retraction Watch tipster who alerted us to this retraction explained what the original paper reported: Continue reading Stanford group retracts JACS paper, but revisits and validates findings

Forget chocolate on Valentine’s Day, try semen, says Surgery News editor. Retraction, resignation follow

We have a bizarre tale to relate involving the journal Surgery News, which recently lost its editor-in-chief over a rather strange editorial he wrote in the February issue of the magazine.

The ill-fated — and, we’ll stipulate, ill-advised — commentary has led to a de facto retraction of the entire publication — meaning that although no retraction notice exists that we’re aware of, neither does the issue exist in the publication’s archives.

But first, some important background. Surgery News is a trade magazine with a complicated structure. The publication, which describes itself as “the official newspaper of the American College of Surgeons [ACS],” is published by Elsevier, which supplies medical news through its International Medical News Group division. The society provides its own news, as well as the lead editor, a surgeon, who until recently was Lazar Greenfield. Greenfield, of the University of Michigan, also happens to be the president-elect of the ACS, twin responsibilities that put him at the pinnacle of influence for his specialty.

Now back to the offending editorial, which we’ll bring you in its entirety since 1) we think given the events that you should read the whole thing, and 2) because the ACS has taken the entire February issue off its website we can’t link to it even if we wanted to (more on that later). Under the heading “Gut Feelings,” Greenfield wrote (we added links): Continue reading Forget chocolate on Valentine’s Day, try semen, says Surgery News editor. Retraction, resignation follow

Another Cell retraction, and more questions than answers

A new retraction has appeared in the journal Cell. The article, “DNA-PKcs-PIDDosome: A Nuclear Caspase-2-Activating Complex with Role in G2/M Checkpoint Maintenance,” had initially appeared in February 2009.

According to the notice: Continue reading Another Cell retraction, and more questions than answers

Where did I park my car? Psychological Science retracts working memory study

In what might be considered a model for how retraction notices should look, Psychological Science has retracted a 2008 paper, “Gaining control: Executive training and far transfer of the ability to resolve interference.” According to the notice — which includes two tables: Continue reading Where did I park my car? Psychological Science retracts working memory study

Elsevier weighs in on Brazilian fraud case

Yesterday, we reported on 11 retractions in various Elsevier chemistry journals of papers from a group of Brazilian scientists who are alleged to have fabricated nuclear magnetic resonance images used in their articles.

We’d spoken with the senior author on those papers, Claudio Airoldi, who defended himself and his colleagues and denied that the NMR images had been manipulated.

Today, we heard from Tom Reller, vice president for global corporate relations at Elsevier, who offered a different version of events.

Here’s what Reller had to say, straight from his email: Continue reading Elsevier weighs in on Brazilian fraud case

Hazardous materials: Elsevier retracts 11 chemistry papers from Brazilian group, citing fraud

The publisher Elsevier has announced that it is retracting 11 papers from a team of Brazilian researchers over concerns that the scientists committed fraud in the studies.

The notice is pegged to an October 2009 article in the Journal of Colloid and Interface Science titled “Immobilization of 5-amino-1,3,4-thiadiazole-thiol onto kanemite for thorium(IV) removal: Thermodynamics and equilibrium study” by Denis L. Guerra, Marcos A. Carvalho, Victor L. Leidens, Alane A. Pinto, Rúbia R. Viana, and Claudio Airoldi.

According to the notice: Continue reading Hazardous materials: Elsevier retracts 11 chemistry papers from Brazilian group, citing fraud

Freedom from Information Act? Another JBC retraction untarnished by any facts

There’s helpful but uninformative:

Ivan: What’s the weather like today?

Adam: Sunny.

And then there’s uninformative as served up by the Journal of Biological Chemistry.

We’ve already recounted one teeth-grinding experience with the JBC, a publication of the American Society for Biochemistry and Molecular Biology. The case involved two papers in JBC by Axel Ullrich, an esteemed cancer researcher at the Max Planck Institute in Germany. According to Ullrich, one of his then-postdocs, Naohito Aoki, had manipulated figures that appeared in the papers, necessitating their retraction.

Round two involves another JBC retraction of a 2000 paper by Aoki and co-author Tsukasa Matsuda, titled ‘A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.’ The paper has been cited more than 100 times, according to Thomson Scientific’s Web of Knowledge.

According to the notice: Continue reading Freedom from Information Act? Another JBC retraction untarnished by any facts

Another retraction of Spirocor research

Remember Spirocor, the Israeli company that closed down a clinical trial involving its “respiratory stress” test for coronary artery disease because the data underpinning the validity of the method proved unreliable? The problem led to the retraction of two articles, about which we’ve previously reported. But we also found a study by some of the same researchers, who include scientists in Israel and the United States, that had been presented at the 2010 meeting of the American Heart Association and published in the journal Circulation.

That abstract, No. 14426 “Accuracy and Usefulness of Finger Pulse Wave Analysis during Brief Deep Breathing Exercise (Respiratory Stress Response) as a Marker of Significant Coronary Artery Disease,” has now been retracted — making, to our knowledge, the entire body of published research on the Spirocor product an editorial memory.

Here’s the notice, which appears within the text of the abstract: Continue reading Another retraction of Spirocor research

Sigh: “The purpose of keeping these retraction notices slim is not to produce too much detail”

Regular readers of this blog by now know that one of our goals is to make retractions as open and informative as possible. Which is why when they’re not, we get irritated that not everyone seems to agree.

Consider the editors of Computational and Theoretical Chemistry, which this month has retracted two papers from a group of researchers in Iran. The articles were titled “Determination of the electrode potentials for substituted 1,2-dihydroxybenzenes in aqueous solution: Theory and experiment” first published online in July 2006 and cited 25 times, according to the Thomson Scientific Web of Knowledge, and “Calculation of electrode potentials of 5-(1,3-dioxo-2-phenyl-indan-2-yl)-2,3-dihydroxy-benzoic acid, molecular structure and vibrational spectra: A combined experimental and computational study,” which appeared in December 2006. (Both articles were published in the journal’s previous incarnation as the Journal of  Molecular Structure: THEOCHEM.)

The reason given in each case  is the same — and tantalizingly cryptic: Continue reading Sigh: “The purpose of keeping these retraction notices slim is not to produce too much detail”

In a retraction’s wake: Postdoc Shane Mayack, dismissed from Amy Wagers’ stem cell lab, speaks out

 

Last October, Retraction Watch readers will recall, up-and-coming stem cell researcher Amy Wagers retracted a study in Nature describing how her team rejuvenated blood-forming stem cells in older mice. Shane Mayack, a postdoc in Wagers’ lab who had been dismissed after an inquiry into what happened, did not sign that retraction. Since then, Mayack has not spoken to the press, except for a brief comment to Nature through her attorney.

Here, we present, unedited, Mayack’s side of the story. While accepting responsibility, she also has a number of suggestions for how universities and journals can handle these situations better. Shane can be reached at smayck[at]yahoo.com.

Since it was well covered by this blog, the readers of Retraction Watch are no doubt aware that in October 2010, a paper that I co-authored was retracted from Nature and a notice of concern was posted regarding a second paper published in Blood.

So, what went wrong? Continue reading In a retraction’s wake: Postdoc Shane Mayack, dismissed from Amy Wagers’ stem cell lab, speaks out